Back
Janux Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
JANX
Janux Therapeutics, Inc.
Last Price:
$13.85
Seasonality Move:
51.13%
7 Day Trial
ALL ACCESS PASS
$
7
Janux Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Janux Therapeutics, Inc. has on average historically risen by 90.5% based on the past 4 years of stock performance.
-
Janux Therapeutics, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is Janux Therapeutics, Inc. Stock Undervalued?The current Janux Therapeutics, Inc. [JANX] share price is $13.79. The Score for JANX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Janux Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Janux Therapeutics, Inc. has on average historically risen by 90.5% based on the past 4 years of stock performance.
Janux Therapeutics, Inc. Stock Rating
Sell
36
Janux Therapeutics, Inc. (JANX)
is a Sell
Is Janux Therapeutics, Inc. overpriced?
-
Janux Therapeutics, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
Janux Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
januxrx.com
52-Week Data
52-Week High:
61.59
52-Week Low:
13.76
Prediction Charts
Market Cap:
829.4M
Price in USD:
13.79
Volume:
7.6M
Beta:
2.87
Technical Analysis
SMA50:
24.81
SMA100:
24.31
SMA200:
25.58
52-Wk Change:
-75.7%
Stock Predictions
-
Is Janux Therapeutics, Inc. stock public?Yes, Janux Therapeutics, Inc. is a publicly traded company.
-
What is the Janux Therapeutics, Inc. stock quote today?The Janux Therapeutics, Inc. stock price is 13.79 USD today.
-
How to buy Janux Therapeutics, Inc. stock online?You can buy Janux Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 18.51 | 15.86 | 18.86 | 15.77 |
| Dec-3 | 15.97 | 17.11 | 17.37 | 15.51 |
| Dec-4 | 17.05 | 16.40 | 17.22 | 16.30 |
| Dec-5 | 16.40 | 16.51 | 16.54 | 16.00 |
| Dec-8 | 16.74 | 16.58 | 17.13 | 16.03 |
| Dec-9 | 16.55 | 15.74 | 16.77 | 15.67 |
| Dec-10 | 15.60 | 15.58 | 15.82 | 15.28 |
| Dec-11 | 15.63 | 15.36 | 15.76 | 15.26 |
| Dec-12 | 15.37 | 15.30 | 15.59 | 15.16 |
| Dec-15 | 15.53 | 15.12 | 15.58 | 14.85 |
| Dec-16 | 15.18 | 14.65 | 15.18 | 14.60 |
| Dec-17 | 14.61 | 14.10 | 14.99 | 14.02 |
| Dec-18 | 14.18 | 14.04 | 14.40 | 13.80 |
| Dec-19 | 14.10 | 13.79 | 14.50 | 13.76 |
Janux Therapeutics, Inc. Earnings
Janux Therapeutics, Inc. Earnings Report: Per Share Janux Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Janux Therapeutics, Inc. Forecast Revenue Growth
Janux Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Janux Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.67 per share, and a decrease next year of $1.00 per share.
* Janux Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.